Cann Group

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, Cann Group had revenue of €2.44m and net profit of -€3.67m

(EUR)	June 2026	YoY
Revenue	2.44m	-
Gross profit	-2.18m	-
Net profit	-3.67m	-
EBITDA	-1.77m	-

Fundamentals

Metric	Value
Market capitalization	€5.21m
Number of shares	1.66bn
52-week high/low	€0.0179 - €0.00134
Dividends	No
Beta	0.11
P/E ratio	0.30
PEG ratio	0.00
P/B ratio	0.07
P/S ratio	0.97

Company profile

Cann Group Limited focuses on breeding, cultivating, manufacturing, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Bundoora, Australia.